GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Long-Term Debt

Organon Pharma Indonesia PT (ISX:SCPI) Long-Term Debt : Rp0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Long-Term Debt?

Organon Pharma Indonesia PT's Long-Term Debt for the quarter that ended in . 20 was Rp0.00 Mil.


Organon Pharma Indonesia PT Long-Term Debt Historical Data

The historical data trend for Organon Pharma Indonesia PT's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Long-Term Debt Chart

Organon Pharma Indonesia PT Annual Data
Trend
Long-Term Debt

Organon Pharma Indonesia PT Quarterly Data
Long-Term Debt

Organon Pharma Indonesia PT  (ISX:SCPI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Organon Pharma Indonesia PT Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines